![Troy Ignelzi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 416 700 $ in data 30/06/2026
Mr. Troy A. Ignelzi is an Independent Director at Harmony Biosciences Holdings, Inc., an Independent Director at Contineum Therapeutics, Inc., a Chief Financial Officer at Rapport Therapeutics, Inc. and a Chairman at Vedanta Biosciences, Inc. He is on the Board of Directors at Harmony Biosciences Holdings, Inc., Contineum Therapeutics, Inc. and Abivax SA. Mr. Ignelzi was previously employed as an Independent Director by CinCor Pharma, Inc., a Chief Financial Officer by Karuna Therapeutics, Inc., a Chief Financial & Accounting Officer by scPharmaceuticals, Inc., a Chief Financial Officer by Juventas Therapeutics, Inc., a Senior VP-Operations & Business Development by PharmaLex GmbH, a Vice President by Esperion Therapeutics, Inc., and a VP-Business Development & Strategic Planning by InSys Therapeutics, Inc. /Old/.
He received his undergraduate degree from Ferris State University (Michigan).
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 14/04/2026 | 10.000 ( 0,02% ) | 416 700 $ | 30/06/2026 | |
| 26/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 | |
| 02/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 | |
ABIVAX SA -.--% | 28/02/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ABIVAX | Direttore/Membro del Consiglio | 11/07/2023 |
| RAPPORT THERAPEUTICS, INC. | Direttore Finanziario/CFO | 01/11/2023 |
| CONTINEUM THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 20/05/2024 |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Direttore/Membro del Consiglio | 02/04/2026 |
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Presidente | - |
| Società | Posizione | Fine |
|---|---|---|
| KARA THER | Direttore Finanziario/CFO | 29/09/2023 |
| CINCOR PHARMA, INC. | Direttore/Membro del Consiglio | 24/02/2023 |
| SCPHARMACEUTICALS INC. | Direttore Finanziario/CFO | 28/02/2019 |
Juventas Therapeutics, Inc.
 Juventas Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Provides regenerative therapies for cardiovascular disease | Direttore Finanziario/CFO | 01/02/2016 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 13 |
|---|---|
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Ferris State University (Michigan)
 Ferris State University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InSys Therapeutics, Inc. /Old/
 InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology Manufactures pharmaceutical products | Health Technology |
Juventas Therapeutics, Inc.
Juventas Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Provides regenerative therapies for cardiovascular disease | Health Services |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines for psychiatric and neurological disorders like schizophrenia and Alzheimer’s disease | Health Technology |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
scPharmaceuticals, Inc.
 scPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products to the cardiovascular and infectious diseases | Health Technology |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
PharmaLex GmbH
 PharmaLex GmbH Packaged SoftwareTechnology Services Develops AI and machine learning automation for pharmacy, biotech & med tech industries | Technology Services |
Harmony Biosciences Holdings, Inc.
 Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and trades medicines for cardiovascular, metabolic & kidney diseases | Health Technology |
Pipeline Therapeutics, Inc.
 Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
